Globus Medical EPS - Earnings per Share 2012-2025 | GMED
Globus Medical annual and quarterly earnings per share history from 2012 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Globus Medical EPS for the quarter ending September 30, 2025 was $0.88, a 131.58% increase year-over-year.
- Globus Medical EPS for the twelve months ending September 30, 2025 was $3.10, a 443.86% increase year-over-year.
- Globus Medical 2024 annual EPS was $0.75, a 29.91% decline from 2023.
- Globus Medical 2023 annual EPS was $1.07, a 42.16% decline from 2022.
- Globus Medical 2022 annual EPS was $1.85, a 28.47% increase from 2021.
| Globus Medical Annual EPS | |
|---|---|
| 2024 | $0.75 |
| 2023 | $1.07 |
| 2022 | $1.85 |
| 2021 | $1.44 |
| 2020 | $1.01 |
| 2019 | $1.52 |
| 2018 | $1.54 |
| 2017 | $1.10 |
| 2016 | $1.08 |
| 2015 | $1.17 |
| 2014 | $0.97 |
| 2013 | $0.73 |
| 2012 | $0.80 |
| 2011 | $0.67 |
| Globus Medical Quarterly EPS | |
|---|---|
| 2025-09-30 | $0.88 |
| 2025-06-30 | $1.49 |
| 2025-03-31 | $0.54 |
| 2024-12-31 | $0.19 |
| 2024-09-30 | $0.38 |
| 2024-06-30 | $0.23 |
| 2024-03-31 | $-0.05 |
| 2023-12-31 | $0.01 |
| 2023-09-30 | $0.01 |
| 2023-06-30 | $0.57 |
| 2023-03-31 | $0.48 |
| 2022-12-31 | $0.48 |
| 2022-09-30 | $0.47 |
| 2022-06-30 | $0.53 |
| 2022-03-31 | $0.37 |
| 2021-12-31 | $0.15 |
| 2021-09-30 | $0.45 |
| 2021-06-30 | $0.40 |
| 2021-03-31 | $0.44 |
| 2020-12-31 | $0.53 |
| 2020-09-30 | $0.44 |
| 2020-06-30 | $-0.21 |
| 2020-03-31 | $0.25 |
| 2019-12-31 | $0.43 |
| 2019-09-30 | $0.38 |
| 2019-06-30 | $0.38 |
| 2019-03-31 | $0.33 |
| 2018-12-31 | $0.36 |
| 2018-09-30 | $0.35 |
| 2018-06-30 | $0.44 |
| 2018-03-31 | $0.39 |
| 2017-12-31 | $0.25 |
| 2017-09-30 | $0.26 |
| 2017-06-30 | $0.29 |
| 2017-03-31 | $0.30 |
| 2016-12-31 | $0.25 |
| 2016-09-30 | $0.27 |
| 2016-06-30 | $0.27 |
| 2016-03-31 | $0.29 |
| 2015-12-31 | $0.38 |
| 2015-09-30 | $0.28 |
| 2015-06-30 | $0.25 |
| 2015-03-31 | $0.26 |
| 2014-12-31 | $0.29 |
| 2014-09-30 | $0.24 |
| 2014-06-30 | $0.22 |
| 2014-03-31 | $0.22 |
| 2013-12-31 | $0.22 |
| 2013-09-30 | $0.22 |
| 2013-06-30 | $0.08 |
| 2013-03-31 | $0.21 |
| 2012-12-31 | $0.22 |
| 2012-09-30 | $0.18 |
| 2012-06-30 | $0.21 |
| 2012-03-31 | $0.19 |
| 2011-12-31 | $0.15 |
| 2011-09-30 | $0.19 |
| 2011-06-30 | $0.18 |
| 2011-03-31 | $0.16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $12.566B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $234.686B | 27.89 |
| Intuitive Surgical (ISRG) | United States | $194.058B | 75.92 |
| IDEXX Laboratories (IDXX) | United States | $56.864B | 56.47 |
| Edwards Lifesciences (EW) | United States | $49.030B | 32.88 |
| IQVIA Holdings (IQV) | United States | $41.090B | 22.91 |
| Alcon (ALC) | Switzerland | $39.297B | 26.56 |
| Mettler-Toledo (MTD) | United States | $30.573B | 35.77 |
| DexCom (DXCM) | United States | $27.005B | 37.23 |
| STERIS (STE) | Ireland | $26.329B | 27.18 |
| Waters (WAT) | United States | $23.497B | 31.07 |
| Coloplast (CLPBY) | Denmark | $20.013B | 34.15 |
| Hologic (HOLX) | United States | $16.722B | 17.57 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.356B | 0.00 |
| Penumbra (PEN) | United States | $13.726B | 96.55 |
| Masimo (MASI) | United States | $7.513B | 24.07 |
| Glaukos (GKOS) | United States | $6.575B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.270B | 19.92 |
| TransMedics (TMDX) | United States | $4.911B | 58.17 |
| Teleflex (TFX) | United States | $4.623B | 7.37 |
| LivaNova (LIVN) | United Kingdom | $3.451B | 18.64 |
| Veracyte (VCYT) | United States | $3.241B | 36.94 |
| Integer Holdings (ITGR) | United States | $2.988B | 14.03 |
| Alphatec Holdings (ATEC) | United States | $2.594B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.422B | 22.66 |
| Artivion (AORT) | United States | $2.051B | 94.11 |
| UFP Technologies (UFPT) | United States | $1.985B | 26.21 |
| Nihon Kohden (NHNKY) | Japan | $1.954B | 17.06 |
| PROCEPT BioRobotics (PRCT) | United States | $1.704B | 0.00 |
| AxoGen (AXGN) | United States | $1.440B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.429B | 0.00 |
| IRadimed (IRMD) | United States | $1.305B | 62.16 |
| Integra LifeSciences Holdings (IART) | United States | $0.985B | 5.34 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.956B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.783B | 0.00 |
| SiBone (SIBN) | United States | $0.763B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.709B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.681B | 39.60 |
| Alpha Tau Medical (DRTS) | Israel | $0.651B | 0.00 |
| NeuroPace (NPCE) | United States | $0.578B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.43 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.570B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.485B | 13.40 |
| OrthoPediatrics (KIDS) | United States | $0.469B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.454B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.416B | 0.00 |
| RxSight (RXST) | United States | $0.403B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.361B | 60.06 |
| Sight Sciences (SGHT) | United States | $0.349B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.201B | 0.00 |
| 908 Devices (MASS) | United States | $0.200B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.192B | 0.00 |
| Inogen (INGN) | United States | $0.175B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.172B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.169B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.144B | 0.00 |
| CVRx (CVRX) | United States | $0.143B | 0.00 |
| LENSAR (LNSR) | United States | $0.143B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Solana (HSDT) | United States | $0.128B | 0.00 |
| Neuronetics (STIM) | United States | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Accuray (ARAY) | United States | $0.098B | 0.00 |
| DarioHealth (DRIO) | United States | $0.083B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.075B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | United States | $0.068B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.40 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |